Quincy Bioscience (www.quincybioscience.com) is a biotechnology company based in Madison, Wisconsin.  Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process.  The company's products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms.  Quincy Bioscience is developing health applications of the jellyfish protein apoaequorin for dietary supplement and pharmaceutical products.  The company‚Äôs first product, Prevagen (www.prevagen.com), was launched in the fall of 2007 and is intended to supplement the loss of critical calcium-binding proteins depleted in the normal course of healthy aging.